Centrient Pharmaceuticals announces its achievement of a significant milestone in the clean production of antibiotics | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
Being the first company to publicly announce 100% PNEC compliance for its entire oral antibiotics product rangeRijswijk, The Netherlands, May 19, 2022 (GLOBE NEWSWIRE) Summary Centrient Pharmaceuticals
Centrient Pharmaceuticals announces its achievement of a significant milestone in the clean production of antibiotics – Indonesia Tribune indonesiatribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indonesiatribune.com Daily Mail and Mail on Sunday newspapers.
Investegate announcements from Centrient Pharmaceuticals, Centrient Pharmaceuticals announces its achievement of a significant milestone in the clean production of antibiotics
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with .
Centrient PharmaceuticalsFebruary 15, 2021 GMT
Rotterdam, the Netherlands, February 15th, 2021, Feb. 15, 2021 (GLOBE NEWSWIRE)
Further strengthens Centrient Pharmaceuticals’ position as the global business-to-business industry leader in beta-lactam antibiotics
Broadens Centrient Pharmaceuticals’ product portfolio with sterile injectable Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin finished dosage forms, able to further meet the needs of customers in these segments and become a preferred partner for customers
Brings in-house manufacturing capabilities for high-quality sterile antibiotic powder injectable finished dosage forms with two US FDA-approved production lines